DarioHealth Corp. (DRIO) financial statements (2022 and earlier)

Company profile

Business Address 18 W 18TH ST., 5TH FLOOR
NEW YORK, NY 10011
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments35,80828,59020,39510,9973,9761,3182,751
Cash and cash equivalents35,80828,59020,39510,9973,7181,0932,671
Short-term investments    25822580
Restricted cash and investments140135140180   
Receivables4001,500    291
Inventory, net of allowances, customer advances and progress billings6,2282,2931,4141,3771,184888601
Inventory6,2282,2931,4141,3771,184888601
Prepaid expense1,5911,354203454451440622
Deferred costs  2471   
Other current assets768040661536422
Other undisclosed current assets1,362176723168282226 
Total current assets:45,60534,12822,93913,3136,0462,9364,287
Noncurrent Assets
Operating lease, right-of-use asset287498765
Property, plant and equipment702576648733869901749
Intangible assets, net (including goodwill)54,100      
Goodwill41,640      
Intangible assets, net (excluding goodwill)12,460      
Deposits noncurrent assets20201743423541
Other undisclosed noncurrent assets57185200    
Total noncurrent assets:55,1661,2791,630776911936790
TOTAL ASSETS:100,77135,40724,56914,0896,9573,8725,077
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,9155,5003,6804,4283,0152,9251,659
Accounts payable5,1092,4801,6562,5741,8521,812978
Accrued liabilities4,398880887880428622434
Employee-related liabilities3,4082,1401,137974735491247
Deferred revenue1,1951,2241,223
Debt  317    
Deferred revenue and credits  31
Other undisclosed current liabilities266310 736   
Total current liabilities:14,3767,0345,2205,1643,0152,9251,690
Noncurrent Liabilities
Long-term debt and lease obligation21222455    
Operating lease, liability21222455
Liabilities, other than long-term debt825   17,4882,610
Business combination, contingent consideration, liability825      
Derivative instruments and hedges, liabilities    17,4882,610
Total noncurrent liabilities:846444455 17,4882,610
Total liabilities:15,2227,4785,6755,1643,01610,4134,300
Temporary equity, carrying amount      2,357
Stockholders' equity
Stockholders' equity attributable to parent85,54928,15118,8948,9253,941(6,541)(1,580)
Common stock2  8765
Additional paid in capital307,561171,399129,03998,17174,89248,41341,769
Accumulated deficit(222,014)(143,248)(110,145)(89,254)(70,958)(54,960)(43,354)
Total stockholders' equity:85,54928,15118,8948,9253,941(6,541)(1,580)
Other undisclosed liabilities and equity (222)     
TOTAL LIABILITIES AND EQUITY:100,77135,40724,56914,0896,9573,8725,077

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues20,5137,5767,5597,3945,1702,803823
Cost of revenue(12,444)(5,063)(4,962)(5,629)(3,859)(3,633)(1,678)
Cost of goods and services sold(12,444)(5,063)(4,962)(5,629)(3,859)(3,633)(193)
Other undisclosed gross profit(4,106)      
Gross profit:3,9632,5132,5971,7651,311(830)(855)
Operating expenses(80,457)(32,416)(20,302)(19,453)(15,730)(10,271)(6,843)
Operating loss:(76,494)(29,903)(17,705)(17,688)(14,419)(11,101)(7,698)
Nonoperating income (expense)(235)458(31)(115)(1,324)214556
Investment income, nonoperating4461     
Foreign currency transaction gain (loss), before tax(195)446     
Other nonoperating expense  (31)(116)(156)(46)(15)
Other undisclosed income from continuing operations before equity method investments, income taxes      14,284
Income (loss) from continuing operations before income taxes:(76,729)(29,445)(17,736)(17,803)(15,743)(10,887)7,142
Income tax expense(32)      
Net income (loss):(76,761)(29,445)(17,736)(17,803)(15,743)(10,887)7,142
Other undisclosed net loss attributable to parent      (14,284)
Net loss attributable to parent:(76,761)(29,445)(17,736)(17,803)(15,743)(10,887)(7,142)
Preferred stock dividends and other adjustments     (265) 
Other undisclosed net loss available to common stockholders, basic(2,005)(3,658)(3,155)(493)(255)(455)(154)
Net loss available to common stockholders, diluted:(78,766)(33,103)(20,891)(18,296)(15,998)(11,607)(7,296)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(76,761)(29,445)(17,736)(17,803)(15,743)(10,887)7,142
Comprehensive income (loss), net of tax, attributable to parent:(76,761)(29,445)(17,736)(17,803)(15,743)(10,887)7,142

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: